chrX-21432806-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_014927.5(CNKSR2):c.423G>A(p.Trp141*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014927.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Intellectual disability, X-linked, syndromic, Houge type Pathogenic:1
This sequence variant is a single nucleotide substitution (G>A) at coding position 423 of the CNKSR2 gene which changes the Trp141 codon to an early termition sigl. As it occurs in exon 3 of 23, this variant is predicted to generate a non-functiol allele through either the expression of a truncated protein or a loss of CNKSR2 expression due to nonsense-mediated decay. This novel variant is absent from ClinVar, medical publications, and the gnomAD population database (0/~177000 alleles). Haploinsufficiency in CNKSR2 is a known mechanism of disease. Based upon the evidence, we consider this variant to be pathogenic. ACMG Criteria: PM2, PS2, PVS1 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.